![Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-017-2619-1/MediaObjects/11060_2017_2619_Fig1_HTML.gif)
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using.png)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram](https://www.researchgate.net/publication/287497086/figure/fig2/AS:614128121024512@1523430962501/Progression-free-survival-by-IRC-Shown-is-the-Kaplan-Meier-curve-for-estimated-PFS-among.png)
Progression-free survival by IRC Shown is the Kaplan-Meier curve for... | Download Scientific Diagram
![Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis](https://www.frontiersin.org/files/Articles/810580/fonc-12-810580-HTML-r1/image_m/fonc-12-810580-g001.jpg)
Frontiers | Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
![Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/cci/2019/cci.2019.3/cci.19.00013/20190809/images/large/cci.19.00013t1.jpeg)
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig2_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-18/MediaObjects/12885_2013_Article_4261_Fig1_HTML.jpg)
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and.png)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors](https://www.frontiersin.org/files/Articles/566357/fonc-10-01349-HTML/image_m/fonc-10-01349-g002.jpg)
Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
![Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram](https://www.researchgate.net/publication/233746224/figure/fig2/AS:601587995136000@1520441163001/Progression-free-survival-and-overall-survival-curves-for-all-patients-with-different.png)
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig1_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Progression-free survival curve—Kaplan-Meier plot for progression-free... | Download Scientific Diagram Progression-free survival curve—Kaplan-Meier plot for progression-free... | Download Scientific Diagram](https://www.researchgate.net/publication/221776228/figure/fig1/AS:202810701422596@1425365247252/Progression-free-survival-curve-Kaplan-Meier-plot-for-progression-free-survival-for-all.png)
Progression-free survival curve—Kaplan-Meier plot for progression-free... | Download Scientific Diagram
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/profile/Shunsuke-Kondo/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using_Q640.jpg)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-methrespfs-lrg.png)
Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
![Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma](https://www.frontiersin.org/files/Articles/524388/fonc-10-00618-HTML/image_m/fonc-10-00618-g003.jpg)